← Evidence map

ReviewBiomarker research2022

Sestrin2 in cancer: a foe or a friend?

Moein AlaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35527284